Thelansis

HER2 Positive Gastroesophageal Adenocarcinoma (GEA) Market Outlook Thelansis’s “HER2 Positive Gastroesophageal Adenocarcinoma (GEA) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential HER2 Positive Gastroesophageal Adenocarcinoma (GEA)     treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). HER2 Positive Gastroesophageal Adenocarcinoma (GEA) Overview Gastroesophageal cancer is the second most commonly diagnosed type of cancer and is responsible for more than 1.2 million deaths yearly. Adenocarcinoma is the predominant type of gastroesophageal cancer, comprising 60% to 95% of all malignant tumors. With 5-year survival rates under 3...

Eosinophilic Gastritis or Gastroenteritis Market Outlook Thelansis’s “Eosinophilic Gastritis or Gastroenteritis Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Eosinophilic Gastritis or Gastroenteritis     treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Eosinophilic Gastritis or Gastroenteritis Overview Eosinophilic esophagitis is the most commonly recognized EDD. Patients often present with symptoms similar to gastroesophageal reflux disease; however, they are not responsive to traditional antireflux therapy. Emerging data suggest that using acid-suppressive medications may predispose patients to develop eosinophilic esop...

Infantile Spasms (IS) Market Outlook Thelansis’s “Infantile Spasms (IS) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Infantile Spasms (IS)     treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Infantile Spasms (IS) Overview Infantile spasms, also known as West syndrome, represent a distinct and often devastating form of epilepsy affecting infants. It is characterized by unique seizure episodes called infantile spasms, which manifest as flexor, extensor, or mixed flexor-extensor spasms. These spasms are accompanied by a distinctive electroencephalography (EEG) pattern known as hypsarrhythmia a...

Esophageal Cancer Market Outlook Thelansis’s “Esophageal Cancer Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Esophageal Cancer     treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Esophageal Cancer Overview Esophageal cancer is the seventh leading cause of death in males in the United States (US). Squamous cell carcinoma is the most common histology for EC worldwide; however, adenocarcinoma is the most predominant histology in the US. Early-stage EC may be totally asymptomatic or may present with mild nonspecific symptoms such as heartburn, atypical chest pain, or dyspepsia. Alternatively, patients may present with sympt...

Opioid Overdose Market Outlook Thelansis’s “Opioid Overdose Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Opioid Overdose     treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Opioid Overdose Overview The term “opioids” encompasses compounds derived from the poppy plant (Papaver somniferum), along with semisynthetic and synthetic counterparts sharing similar properties that can engage with opioid receptors in the brain. Opioids, such as morphine, codeine, and fentanyl, are commonly employed for pain management due to their analgesic and sedative effects. Medications like methadone and buprenorphine are used for the mainten...

Follicular Lymphoma (FL) Market Outlook Thelansis’s “Follicular Lymphoma (FL) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Follicular Lymphoma (FL)     treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Follicular Lymphoma (FL) Overview Follicular lymphoma, accounting for approximately  20–30% of all non-Hodgkin lymphomas , is the most common subtype of indolent (low-grade) B-cell lymphoma. It arises from germinal center B cells and is typically identified histologically by neoplastic follicles that disrupt normal lymph node architecture, with tumor cells arranged in circular or clustered patterns. The underlying caus...

Sickle Cell Disease (SCD) Market Outlook Thelansis’s “Sickle Cell Disease (SCD) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Sickle Cell Disease (SCD)     treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Sickle Cell Disease (SCD) Overview Sickle cell disease (SCD) results from homozygous and compound heterozygote inheritance of a mutation in the β-globin gene. This genetic anomaly leads to the formation of dense and rigid red blood cells (RBCs), particularly those containing HbS or HbS in combination with other abnormal β alleles. When exposed to a deoxygenated environment, these RBCs undergo polymerization, becoming rig...

Alcoholic Hepatitis (AH) Market Outlook Thelansis’s “Alcoholic Hepatitis (AH) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Alcoholic Hepatitis (AH)     treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Alcoholic Hepatitis (AH) Overview Alcohol stands as one of the most commonly consumed substances globally, socially embraced despite its harmful effects on the liver. Excessive alcohol intake results in various health issues, leading to substantial healthcare expenses related to alcohol-induced disorders. Among these, Alcoholic Hepatitis (AH) emerges as a critical and potentially life-threatening condition. This acute liver...

Basal Cell Carcinoma (BCC) Market Outlook Thelansis’s “Basal Cell Carcinoma (BCC) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Basal Cell Carcinoma (BCC)     treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Basal Cell Carcinoma (BCC) Overview Basal Cell Carcinoma (BCC), commonly referred to as basal cell skin cancer, usually appears as a slowly growing tumor that tends to invade surrounding tissues rather than spread to distant parts of the body. This type of cancer originates from the epidermis or hair follicles. It is more common in men and is linked to areas with high ultraviolet (UV) exposure, such as regions at lowe...

Wolfram Syndrome Market Outlook Thelansis’s “Wolfram Syndrome Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Wolfram Syndrome     treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Wolfram Syndrome Overview Wolfram syndrome, also referred to as DIDMOAD, is a hereditary condition commonly characterized by childhood-onset insulin-dependent diabetes mellitus and progressive optic atrophy. It is caused by mutations in two genes: WFS1 (4p16.1) and CISD2 (4q24). WFS1 produces Wolframin, a protein in the endoplasmic reticulum (ER) that maintains calcium levels and responds to unfolded protein...